Overview

Steady State Study of Codeine Sulfate

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Study to characterize the steady-state pharmacokinetics of codeine and its metabolites morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) after oral administration of Roxane Laboratories' codeine sulfate tablets administered at a dose of 15 mg Q4H x 5 days.
Phase:
Phase 1
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Codeine